Search
for

    GlossaryProteoglycan Replacement Therapy

    treatment to restore essential molecules for hair follicle health

    Proteoglycan Replacement Therapy is a treatment aimed at restoring the levels of proteoglycans, which are essential molecules in the extracellular matrix of tissues, including the scalp. These molecules play a crucial role in maintaining the structure and function of hair follicles, and their deficiency can lead to conditions like alopecia. By replenishing proteoglycans, this therapy aims to promote hair growth and improve hair health.

    Related Terms

    Research

    5 / 890 results

    Community Join

    5 / 1000+ results

      community Peptide Therapy -> GHK-CU, ZN-Thumulin, PTD-DBM

      in Research/Science  4 upvotes 2 years ago
      The conversation is about the use of peptide therapies for hair loss, specifically GHK-CU, ZN-Thymulin, and PTD-DBM. The user is seeking feedback on the effectiveness of these treatments from those who have tried them.

      community Best Treatment In The Pipeline?

      in Chat  15 upvotes 1 year ago
      New treatments for AGA are emerging, including pyrilutumide, gt0029, scube3, kx-826, and pp405. Verteporfin is mentioned as a promising option.

      community OND-1 "Cyclosporine A” New hair loss treatment

      in Research/Science  28 upvotes 1 week ago
      Orient Bio is developing a PLGA formulated version of Cyclosporine A to stimulate hair growth without its immunosuppressant effects. Users discuss various treatments like Clascoterone, PP405, minoxidil, and tacrolimus, expressing hope for new developments and sharing personal experiences with these treatments.

      community IGF-1 and Peptides? Miracle molecule waiting to be found

      in Research/Science  10 upvotes 7 months ago
      The conversation discusses potential hair loss treatments focusing on stimulating IGF-1 at the follicle level using growth-factor cocktails and engineered peptides, such as Acetyl Tetrapeptide-3, Copper Tripeptide-1, Oligopeptide-20, Thymosin-β4, and Palmitoyl Tetrapeptide-7. It suggests that device-assisted delivery methods like microneedling may enhance effectiveness.